The lack of a radiosensitizing effect of MK-2206 on GBM cell lines found in our study differs from the findings of Chautard et al. (2010) who showed a moderate increase of radiation sensitivity of two glioma cell lines treated with the Akt inhibitor IV (B2311) [21]. The gene discussed is AKT1; the disease is glioma.